Deakin University
Browse

ASO Author Reflections: Important Factors for Adjuvant Immunotherapy Treatment Decisions for Stage II–IV Melanoma Patients and Their Clinicians

Version 2 2024-06-06, 05:21
Version 1 2023-04-28, 06:36
journal contribution
posted on 2024-06-06, 05:21 authored by Ann LivingstoneAnn Livingstone, RL Morton
ASO Author Reflections: Important Factors for Adjuvant Immunotherapy Treatment Decisions for Stage II–IV Melanoma Patients and Their Clinicians

History

Journal

Annals of Surgical Oncology

Volume

27

Pagination

585-586

Location

Berlin, Germany

ISSN

1068-9265

eISSN

1534-4681

Language

eng

Publication classification

C4 Letter or note

Issue

2

Publisher

Springer

Usage metrics

    Research Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC